2,770,569 A 11, 1956 Fromherz et al. 2.945, 049 A 7/1960 Chang et al. 2.981, 641 A 4, 1961
O'Neill 3, 071509 A 1, 1963 O'Neil 3,332,950 A 7/1967 Blumberg et al. 3,493,657 A 2, 1970 …

The present invention provides compositions, meth ods and kits for treating or preventing a
CNS disorder. In general, the invention involves utilizing caffeine for prevent ing or …

BACKGROUND 0003) Opioids, also called opioid agonists, are a class of drugs that exhibit
opium-like or morphine-like properties. The opioids are employed primarily as moderate to …

Provided herein is a pharmaceutical composition comprising an antagonist, an agonist, a
seal coat, and a sequestering polymer, wherein the antagonist, agonist, seal coat and at …

Provided herein is a pharmaceutical composition comprising an antagonist, an agonist, a
seal coat, and a sequestering polymer, wherein the antagonist, agonist, seal coat and at …

393 87 Eight 1 A sequestering subunit comprising an aversive agent and a- achter et al.
3,845,770 11/1974 Theeuwes et al. blocking agent, wherein the blocking agent …

3,845,770 A 1 1/1974 Theeuwes et al. A sequestering subunit comprising an aversive agent
and a SES A 12: Mfish etal blocking agent, wherein the blocking agent Substantially pre …

US20110014295A1 - Method of determining the weight of the coating to be applied to form
a controlled release dosage form - Google Patents US20110014295A1 - Method of …